Correction to: Bone Marrow Transplantation https://doi.org/10.1038/s41409-023-02174-2 published online 06 January 2024
In this article, the author name Elisabeth Dagunet is incorrectly given. It should read Elisabeth Daguenet.
Also, the affiliation 3 EBMT Paris study office; Department of Haematology, Saint Antoine Hospital; INSERM UMR-S 938, Sorbonne University, Paris, France is given incorrectly. It should be CHU de Saint-Etienne, Hematology, Saint-Etienne. France.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Penack, O., Peczynski, C., Boreland, W. et al. Correction: ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party. Bone Marrow Transplant 60, 114 (2025). https://doi.org/10.1038/s41409-024-02435-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-024-02435-8
